We are live on ! Find out more
BDMD

Baird Medical Investment Holdings

6 hedge funds and large institutions have $1.64M invested in Baird Medical Investment Holdings in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.15% more ownership

Funds ownership: 0.86% → 1.01% (+0.15%)

0% more funds holding

Funds holding: 6 → 6 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

18% less capital invested

Capital invested by funds: $1.99M → $1.64M (-$352K)

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

BDMD Hedge Fund Activity: Q1 2025 in Review

6 of the 7,476 institutional investors tracked by Wall St. Rank reported a position in Baird Medical Investment Holdings (BDMD) for Q1 2025, worth a combined $1.64M — down 18% from $1.99M a quarter earlier.

Fund positioning in BDMD was balanced in Q1 2025: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $333K. The largest seller was Scientech Research LLC, exiting entirely with an estimated $421K sold.

  • 6 institutional investors held Baird Medical Investment Holdings (BDMD) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $1.64M of Baird Medical Investment Holdings stock for Q1 2025, down 18% quarter-over-quarter.
  • 2 funds opened new Baird Medical Investment Holdings positions in Q1 2025 and 2 closed out, a net change of 0 holders.
  • The largest Baird Medical Investment Holdings buyer in Q1 2025 was UBS Group, an estimated $333K added.
  • The largest Baird Medical Investment Holdings seller in Q1 2025 was Scientech Research LLC, an estimated $421K sold.

Based on aggregated 13F filings for Q1 2025.